As of 2025-07-19, the Relative Valuation of Utah Medical Products Inc (UTMD) is 132.30 USD. This relative valuation is based on P/E multiples. With the latest stock price at 55.52 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 138.3%.
The range of the Relative Valuation is 119.41 - 143.09 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.7x - 33.5x | 33.1x |
| Forward P/E multiples | 27.6x - 29.4x | 28.5x |
| Fair Price | 119.41 - 143.09 | 132.30 |
| Upside | 115.1% - 157.7% | 138.3% |
| Date | P/E |
| 2025-07-18 | 13.01 |
| 2025-07-17 | 13.12 |
| 2025-07-16 | 13.16 |
| 2025-07-15 | 13.10 |
| 2025-07-14 | 13.28 |
| 2025-07-11 | 13.22 |
| 2025-07-10 | 13.40 |
| 2025-07-09 | 13.41 |
| 2025-07-08 | 13.49 |
| 2025-07-07 | 13.40 |
| 2025-07-03 | 13.69 |
| 2025-07-02 | 13.47 |
| 2025-07-01 | 13.44 |
| 2025-06-30 | 13.33 |
| 2025-06-27 | 13.54 |
| 2025-06-26 | 13.22 |
| 2025-06-25 | 13.03 |
| 2025-06-24 | 13.05 |
| 2025-06-23 | 12.86 |
| 2025-06-20 | 12.57 |
| 2025-06-18 | 12.58 |
| 2025-06-17 | 12.64 |
| 2025-06-16 | 12.90 |
| 2025-06-13 | 12.92 |
| 2025-06-12 | 13.44 |
| 2025-06-11 | 13.36 |
| 2025-06-10 | 13.42 |
| 2025-06-09 | 13.35 |
| 2025-06-06 | 13.16 |
| 2025-06-05 | 13.13 |
| 2025-06-04 | 13.10 |
| 2025-06-03 | 13.12 |
| 2025-06-02 | 12.82 |
| 2025-05-30 | 12.90 |
| 2025-05-29 | 12.79 |
| 2025-05-28 | 12.66 |
| 2025-05-27 | 12.81 |
| 2025-05-23 | 12.59 |
| 2025-05-22 | 12.57 |
| 2025-05-21 | 12.49 |
| 2025-05-20 | 12.70 |
| 2025-05-19 | 12.76 |
| 2025-05-16 | 12.91 |
| 2025-05-15 | 12.85 |
| 2025-05-14 | 12.74 |
| 2025-05-13 | 12.82 |
| 2025-05-12 | 12.65 |
| 2025-05-09 | 12.56 |
| 2025-05-08 | 12.62 |
| 2025-05-07 | 12.63 |